Browse
Register
Log In
Variables
99 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Neurological phenotypes (CHRIS baseline)
x0nd0092d
Vertigo controls (negative at questions, Interview V2)
Vertigo controls (negative at questions, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0092a
Vertigo (positive at questions, Interview V2 or take N07C drugs)
Vertigo (positive at questions, Interview V2 or take N07C drugs)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0092
Vertigo (positive at questions, Interview V2)
Vertigo (positive at questions, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0091d
Vertigo controls (negative at questions, Interview V1)
Vertigo controls (negative at questions, Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0091
Vertigo (positive at questions, Interview V1)
Vertigo (positive at questions, Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0085d
Dysarthria controls (no dysarthria of any cause, Interview V2)
Dysarthria controls (no dysarthria of any cause, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0085a
Dysarthria (excluding the most common cause-stroke, Interview V2)
Dysarthria (excluding the most common cause-stroke, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0085
Dysarthria (any cause, Interview V2)
Dysarthria (any cause, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0084d
Hemiplegia controls (no hemiplegia of any cause, Interview V2)
Hemiplegia controls (no hemiplegia of any cause, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0084a
Hemiplegia (excluding the most common cause-stroke, Interview V2)
Hemiplegia (excluding the most common cause-stroke, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0084
Hemiplegia (any cause, Interview V2)
Hemiplegia (any cause, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0083d
Stenosis controls (no stenosis, Interview V1)
Stenosis controls (no stenosis, Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0083a
Stenosis with drugs for preventing stroke (Interview V1)
Stenosis with drugs for preventing stroke (Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0083
Stenosis (Interview V1)
Stenosis (Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0082d
Transient ischemic attack controls (no TIA, Interview V2)
Transient ischemic attack controls (no TIA, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0082
Transient ischemic attack (Interview V2)
Transient ischemic attack (Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0081d
Strike controls (no stroke, Interview V2)
Strike controls (no stroke, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0081a
Stroke phenotype (suspected, Interview V2)
Stroke phenotype (suspected, Interview V2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0081
Stroke phenotype
Stroke phenotype
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0074a
Insomnia controls (Interview V1)
Insomnia controls (Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0074
Insomnia controls
Insomnia controls
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0073a
Insomnia (hierarchical approach, Interview V1)
Insomnia (hierarchical approach, Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0073
Insomnia (hierarchical approach)
Insomnia (hierarchical approach)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0072a
Insomnia (trasversal approach 2, Interview V1)
Insomnia (trasversal approach 2, Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0072
Insomnia (trasversal approach 2)
Insomnia (trasversal approach 2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0071a
Insomnia (trasversal approach 1, Interview V1)
Insomnia (trasversal approach 1, Interview V1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0071
Insomnia (trasversal approach 1)
Insomnia (trasversal approach 1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0063
Restless Legs Syndrome controls (negative at RLS-Diagnostic Index )
Restless Legs Syndrome controls (negative at RLS-Diagnostic Index )
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0062b
Restless Legs Syndrome (primary RLS & consuming drugs in right dosage)
Restless Legs Syndrome (primary RLS & consuming drugs in right dosage)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0062a
Restless Legs Syndrome (positive at RLS-Diagnostic Index excluding secondary causes)
Restless Legs Syndrome (positive at RLS-Diagnostic Index excluding secondary causes)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0061c
Restless Legs Syndrome (RLS drugs)
Restless Legs Syndrome (RLS drugs)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0061b
Restless Legs Syndrome (positive at RLS-Diagnostic Index and RLS drugs)
Restless Legs Syndrome (positive at RLS-Diagnostic Index and RLS drugs)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0061a
Restless Legs Syndrome (positive at RLS-Diagnostic Index)
Restless Legs Syndrome (positive at RLS-Diagnostic Index)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0055
Parkinson diseae controls (no diagnosis)
Parkinson diseae controls (no diagnosis)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0054b
Parkinson disease (hierarchical approach 3b)
Parkinson disease (hierarchical approach 3b)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0054a
Parkinson disease (hierarchical approach 3a)
Parkinson disease (hierarchical approach 3a)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0054
Parkinson disease (hierarchical approach 3)
Parkinson disease (hierarchical approach 3)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0053b
Parkinson disease (hierarchical approach 2b)
Parkinson disease (hierarchical approach 2b)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0053a
Parkinson disease (hierarchical approach 2a)
Parkinson disease (hierarchical approach 2a)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0053
Parkinson disease (hierarchical approach 2)
Parkinson disease (hierarchical approach 2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0052b
Parkinson disease (hierarchical approach 1b)
Parkinson disease (hierarchical approach 1b)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0052a
Parkinson disease (hierarchical approach 1a)
Parkinson disease (hierarchical approach 1a)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0052
Parkinson disease (hierarchical approach 1)
Parkinson disease (hierarchical approach 1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0051d1
Parkinson disease (transversal approach 4, modified)
Parkinson disease (transversal approach 4, modified)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0051d
Parkinson disease (transversal approach 4)
Parkinson disease (transversal approach 4)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0051c
Parkinson disease (transversal approach 3)
Parkinson disease (transversal approach 3)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0051b
Parkinson disease (transversal approach 2)
Parkinson disease (transversal approach 2)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0051a
Parkinson disease (transversal approach 1)
Parkinson disease (transversal approach 1)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0043
Tremor controls (no uncontrollable tremor)
Tremor controls (no uncontrollable tremor)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0042
Essential Tremor (secondary causes excluded)
Essential Tremor (secondary causes excluded)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0041
Tremor (uncontrollable tremor)
Tremor (uncontrollable tremor)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0031b
Epilepsy and consuming Anti-EPI drugs
Epilepsy and consuming Anti-EPI drugs
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0031a
Epilepsy (positive at question)
Epilepsy (positive at question)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0025
Normosmia (normal score at the Sniffin' Sticks test and reported normal olfactory sensitivity)
Normosmia (normal score at the Sniffin' Sticks test and reported normal olfactory sensitivity)
Categorical
Neurological phenotypes (CHRIS baseline)
x0nd0024
Hyposmia (based on the Sniffin' Sticks score 9-11)
Hyposmia (based on the Sniffin' Sticks score 9-11)
Categorical
Neurological phenotypes (CHRIS baseline)
x0nd0023
Hyposmia
Hyposmia
Categorical
Neurological phenotypes (CHRIS baseline)
x0nd0022
Anosmia (based on the Sniffin' Sticks score 0-8)
Anosmia (based on the Sniffin' Sticks score 0-8)
Categorical
Neurological phenotypes (CHRIS baseline)
x0nd0021
Anosmia
Anosmia
Categorical
Neurological phenotypes (CHRIS baseline)
x0nd0019
Migraine controls (broad, no symptoms of headache of clinical relevance)
Migraine controls (broad, no symptoms of headache of clinical relevance)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0018
Migraine controls (more strict, no symptoms of headache)
Migraine controls (more strict, no symptoms of headache)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0017a
Any headache, Interview V2
Any headache, Interview V2
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0017
Any headache
Any headache
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0016
Hypnic headache
Hypnic headache
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0015
Cluster headache
Cluster headache
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0014
Tension-type headache
Tension-type headache
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0013a
Any migraine with N02C Drugs
Any migraine with N02C Drugs
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0013
Any Migraine
Any Migraine
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0012b
Migraine with aura and drugs for attack/prevention
Migraine with aura and drugs for attack/prevention
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0012a
Migraine with aura and drugs for attack
Migraine with aura and drugs for attack
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0012
Migraine with aura
Migraine with aura
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0011b
Migraine without aura and drugs for attack/prevention
Migraine without aura and drugs for attack/prevention
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0011a
Migraine without aura and drugs for attack
Migraine without aura and drugs for attack
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0011
Migraine without aura
Migraine without aura
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0008b
Multisite Chronic Pain at two or more body sites
Multisite Chronic Pain at two or more body sites
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0008a
Multisite Chronic Pain by number of body sites
Multisite Chronic Pain by number of body sites
Integer
Neurological phenotypes (CHRIS baseline)
x0nd0007b
Severe chronic pain
Severe chronic pain
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0007a
Severe chronic pain with drug therapy
Severe chronic pain with drug therapy
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0006d
Joint pain controls, Interview V1
Joint pain controls, Interview V1
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0006b
Joint pain without drugs, Interview V1
Joint pain without drugs, Interview V1
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0006a
Joint pain with drugs, Interview V1
Joint pain with drugs, Interview V1
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0005d
Joint pain controls
Joint pain controls
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0005b
Joint pain (hierarchical approach)
Joint pain (hierarchical approach)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0005a
Joint pain (transversal approach)
Joint pain (transversal approach)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0004d
Thoracic back pain controls
Thoracic back pain controls
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0004c
Thoracic back pain with prescribed/GP recommended painkillers
Thoracic back pain with prescribed/GP recommended painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0004b
Thoracic back pain with painkillers
Thoracic back pain with painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0004a
Thoracic back pain
Thoracic back pain
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0003d
Cervical back pain controls (absence of neck pain)
Cervical back pain controls (absence of neck pain)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0003c
Cervical back pain (neck pain) with prescribed/GP recommended painkillers
Cervical back pain (neck pain) with prescribed/GP recommended painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0003b
Cervical back pain (neck pain) with painkillers
Cervical back pain (neck pain) with painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0003a
Cervical back pain (neck pain)
Cervical back pain (neck pain)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0002d
Lumbosacral back pain controls (absence of lower back pain)
Lumbosacral back pain controls (absence of lower back pain)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0002c
Lumbosacral back pain (lower back pain) with prescribed/GP recommended painkillers
Lumbosacral back pain (lower back pain) with prescribed/GP recommended painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0002b
Lumbosacral back pain (lower back pain) with painkillers
Lumbosacral back pain (lower back pain) with painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0002a
Lumbosacral back pain (lower back pain)
Lumbosacral back pain (lower back pain)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0001d
Dorsalgia controls (absence of back pain)
Dorsalgia controls (absence of back pain)
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0001c
Dorsalgia with prescribed/GP recommended painkillers
Dorsalgia with prescribed/GP recommended painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0001b
Dorsalgia with painkillers
Dorsalgia with painkillers
Boolean
Neurological phenotypes (CHRIS baseline)
x0nd0001a
Dorsalgia (backpain in general, unspecified localization)
Dorsalgia (backpain in general, unspecified localization)
Boolean